{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T18:07:32Z","timestamp":1774202852432,"version":"3.50.1"},"reference-count":39,"publisher":"Medknow","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Mycobacteriol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/ijmy.ijmy_141_19","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T13:02:53Z","timestamp":1574341373000},"page":"333","source":"Crossref","is-referenced-by-count":10,"title":["Insights in tuberculosis immunology: Role of NKT and T regulatory cells"],"prefix":"10.4103","volume":"8","author":[{"given":"UrvashiBalbir","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AnujKumar","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anant","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KuldeepSingh","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhu","family":"Vajpayee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BimalKumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JyotishChandra","family":"Samantaray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randeep","family":"Guleria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"key-10.4103\/2212-5531.271472-1","unstructured":"World Health Organization. Global Tuberculosis Report. World Health Organization; 2015. Available from: http:\/\/www.who.int\/tb\/publications\/global_report\/en\/. [Last accessed on 2016 Feb 01]."},{"key":"key-10.4103\/2212-5531.271472-2","first-page":"37","article-title":"Immunotherapy for tuberculosis: Future prospects","author":"Abate","year":"2016","journal-title":"Immunotargets Ther"},{"key":"key-10.4103\/2212-5531.271472-3","first-page":"200","article-title":"Killing of mycobacterium tuberculosis within human monocytes: Activation by cytokines and calcitriol","author":"Denis","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"key-10.4103\/2212-5531.271472-4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/IAI.50.1.1-8.1985","article-title":"Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria","author":"Douvas","year":"1985","journal-title":"Infect Immun"},{"key":"key-10.4103\/2212-5531.271472-5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/IAI.14.2.337-344.1976","article-title":"Partial characterization of a factor extracted from sensitized lymphocytes that inhibits the growth of Mycobacterium tuberculosis within macrophages in vitro","author":"Turcotte","year":"1976","journal-title":"Infect Immun"},{"key":"key-10.4103\/2212-5531.271472-6","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1084\/jem.163.5.1162","article-title":"Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis","author":"Toossi","year":"1986","journal-title":"J Exp Med"},{"key":"key-10.4103\/2212-5531.271472-7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0041-3879(87)90055-9","article-title":"T4 lymphopenia in human tuberculosis","author":"Onwubalili","year":"1987","journal-title":"Tubercle"},{"key":"key-10.4103\/2212-5531.271472-8","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1685","article-title":"T-lymphocytes with gamma delta+V delta 2+ antigen receptors are present in increased proportions in a fraction of patients with tuberculosis or with sarcoidosis","author":"Balbi","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"key-10.4103\/2212-5531.271472-9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/infdis\/165.3.506","article-title":"Gamma delta T lymphocytes in human tuberculosis","author":"Barnes","year":"1992","journal-title":"J Infect Dis"},{"key":"key-10.4103\/2212-5531.271472-10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1365-2249.2002.01809.x","article-title":"Immunophenotypic characterization of peripheral T lymphocytes in mycobacterium tuberculosis infection and disease","author":"Rodrigues","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"key-10.4103\/2212-5531.271472-11","first-page":"98","article-title":"B-lymphocytes and co-stimulatory molecules in Mycobacterium tuberculosis infection","author":"Corominas","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.4103\/2212-5531.271472-12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1054\/tube.2001.0309","article-title":"Reduced NK activity in pulmonary tuberculosis patients with\/without HIV infection: Identifying the defective stage and studying the effect of interleukins on NK activity","author":"Nirmala","year":"2001","journal-title":"Tuberculosis (Edinb)"},{"key":"key-10.4103\/2212-5531.271472-13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4103\/ijmy.ijmy_145_17","article-title":"Risk factors for tuberculosis and beyond","author":"Al-Hajoj","year":"2017","journal-title":"Int J Mycobacteriol","ISSN":"https:\/\/id.crossref.org\/issn\/2212-5531","issn-type":"print"},{"key":"key-10.4103\/2212-5531.271472-14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijmyco.2013.04.006","article-title":"Alteration of human macrophages microRNA expression profile upon infection with Mycobacterium tuberculosis","author":"Furci","year":"2013","journal-title":"Int J Mycobacteriol","ISSN":"https:\/\/id.crossref.org\/issn\/2212-5531","issn-type":"print"},{"key":"key-10.4103\/2212-5531.271472-15","unstructured":"Central TB Division Ministry of Health and Family Welfare. Training Module for Medical Practitioners. New Delhi, India: Central TB Division Ministry of Health and Family Welfare; 2010."},{"key":"key-10.4103\/2212-5531.271472-16","first-page":"775","article-title":"Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria","author":"Kubica","year":"1963","journal-title":"Am Rev Respir Dis"},{"key":"key-10.4103\/2212-5531.271472-17","unstructured":"Central TB Division Ministry of Health and Family Welfare. Training Manual for Mycobacterium tuberculosis Culture and Drug Susceptibility Testing. New Delhi, India: Central TB Division Ministry of Health and Family Welfare; 2009."},{"key":"key-10.4103\/2212-5531.271472-18","unstructured":"Siddiqi SH, Rusch Gerdes S. MGIT Procedure Manual. Geneva, Switzerland: Foundation for Innovative New Diagnostics; 2006."},{"key":"key-10.4103\/2212-5531.271472-19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/JCM.05188-11","article-title":"Direct drug susceptibility testing of Mycobacterium tuberculosis for rapid detection of multidrug resistance using the bactec MGIT 960 system: A multicenter study","author":"Siddiqi","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/2212-5531.271472-20","unstructured":"World Health Organization. Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Anti-Tuberculosis Drugs. World Health Organization; 2008."},{"key":"key-10.4103\/2212-5531.271472-21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1164\/rccm.201707-1475OC","article-title":"Bcells producing type I IFN modulate macrophage polarization in tuberculosis","author":"B\u00e9nard","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/2212-5531.271472-22","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.4049\/jimmunol.157.9.4222","article-title":"Disease-specific changes in gammadelta T cell repertoire and function in patients with pulmonary tuberculosis","author":"Li","year":"1996","journal-title":"J Immunol"},{"key":"key-10.4103\/2212-5531.271472-23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1378\/chest.102.1.195","article-title":"Increased proportions of peripheral blood gamma delta T cells in patients with pulmonary tuberculosis","author":"Ito","year":"1992","journal-title":"Chest"},{"key":"key-10.4103\/2212-5531.271472-24","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.4049\/jimmunol.171.11.6039","article-title":"NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection","author":"Junqueira-","year":"2003","journal-title":"J Immunol"},{"key":"key-10.4103\/2212-5531.271472-25","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4049\/jimmunol.172.2.943","article-title":"Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides","author":"Ortaldo","year":"2004","journal-title":"J Immunol"},{"key":"key-10.4103\/2212-5531.271472-26","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/infdis\/jiy034","article-title":"Interleukin-21 regulates natural killer cell responses during Mycobacterium tuberculosis infection","author":"Paidipally","year":"2018","journal-title":"J Infect Dis"},{"key":"key-10.4103\/2212-5531.271472-27","first-page":"5031","article-title":"Elevated expression of Tim-3 in CD56 dim CD16+ NK cells correlates with disease severity of pulmonary tuberculosis","author":"Huang","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"key":"key-10.4103\/2212-5531.271472-28","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1128\/IAI.70.11.6302-6309.2002","article-title":"Activation of NKT cells protects mice from tuberculosis","author":"Chackerian","year":"2002","journal-title":"Infect Immun"},{"key":"key-10.4103\/2212-5531.271472-29","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1164\/rccm.200508-1294OC","article-title":"Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis","author":"Guyot-Revol","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/2212-5531.271472-30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1164\/rccm.200701-084OC","article-title":"Regulatory T cells depress immune responses to protective antigens in active tuberculosis","author":"Hougardy","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.4103\/2212-5531.271472-31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cei.12804","article-title":"Phenotypical characterization of regulatory T cells in humans and rodents","author":"Rodr\u00edguez-Perea","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"key-10.4103\/2212-5531.271472-32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12865-018-0266-8","article-title":"Immune activation and regulatory T cells in Mycobacterium tuberculosis infected lymph nodes","author":"Sahmoudi","year":"2018","journal-title":"BMC Immunol"},{"key":"key-10.4103\/2212-5531.271472-33","first-page":"45","article-title":"Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis","author":"de","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.4103\/2212-5531.271472-34","first-page":"234","article-title":"T regulatory cells and immune activation in Mycobacterium tuberculosis infection and the effect of preventive therapy.Scand J Immunol","author":"Wergeland","year":"2011","journal-title":""},{"key":"key-10.4103\/2212-5531.271472-35","first-page":"61","article-title":"Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls.Tuberculosis (Edinb)","author":"Zewdie","year":"2016","journal-title":""},{"key":"key-10.4103\/2212-5531.271472-36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drudis.2009.10.005","article-title":"The quest for biomarkers in tuberculosis","author":"Parida","year":"2010","journal-title":"Drug Discov Today"},{"key":"key-10.4103\/2212-5531.271472-37","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/000456329703400205","article-title":"Elevated concentrations of interleukins and leukotriene in response to Mycobacterium tuberculosis infection","author":"El-Ahmady","year":"1997","journal-title":"Ann Clin Biochem"},{"key":"key-10.4103\/2212-5531.271472-38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/MCP.0b013e328326f42c","article-title":"Biomarkers for tuberculosis disease status and diagnosis","author":"Doherty","year":"2009","journal-title":"Curr Opin Pulm Med"},{"key":"key-10.4103\/2212-5531.271472-39","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/2193-1801-2-686","article-title":"Interleukin-6: A potent biomarker of mycobacterial infection","author":"Singh","year":"2013","journal-title":"Springerplus"}],"container-title":["International Journal of Mycobacteriology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T06:11:15Z","timestamp":1695449475000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ijmyco.org\/text.asp?2019\/8\/4\/333\/271472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"alternative-id":["271472"],"URL":"https:\/\/doi.org\/10.4103\/ijmy.ijmy_141_19","relation":{},"ISSN":["2212-5531"],"issn-type":[{"value":"2212-5531","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}